Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Drug And Gene Delivery Devices Market between 2026 and 2030?

The drug and gene delivery devices market has experienced substantial expansion in recent years. This market is anticipated to expand from $0.67 billion in 2025 to $0.73 billion in 2026, registering a compound annual growth rate (CAGR) of 8.9%. The market’s growth during the historical period stems from factors including the limited availability of advanced delivery devices, a reliance on conventional administration routes, the early stages of gene therapy development, an expanding biologics pipeline, and increased investment in research collaborations.

The drug and gene delivery devices market is anticipated to observe significant expansion in the upcoming years, with its size projected to reach $1.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This increase during the forecast period can be attributed to several factors such as technological progress in viral and non-viral vectors, the growing application of personalized medicine and gene therapy, an increase in regulatory approvals for innovative delivery systems, the expanding use of nanomedicine and LNPs, and the integration of digital monitoring and smart delivery platforms. Foreseen major trends for this period include the advancement of targeted drug and gene therapies, a rise in the adoption of nanoparticle-based delivery systems, increased reliance on viral vectors for gene therapy, the expansion of injectable and non-invasive delivery methods, and a focus on personalized medicine and controlled release technologies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp

Which Drivers Are Expected To Impact The Drug And Gene Delivery Devices Market During The Forecast Period?

The rising acceptance of gene therapy is anticipated to fuel the expansion of the drug and gene delivery devices market. Gene therapy, a medical approach, entails introducing, removing, or modifying genetic material in a patient’s cells to manage or avert illnesses. Demand for gene therapy is escalating as it holds the promise to address genetic and chronic diseases by targeting their fundamental causes, providing groundbreaking treatment alternatives when traditional methods prove insufficient. Crucially, drug and gene delivery devices facilitate gene therapy by enabling the accurate targeting and regulated release of therapeutic genes, thereby boosting treatment effectiveness. For example, the American Society of Gene & Cell Therapy, a US-based non-profit organization, stated in January 2025 that Q4 2024 saw the greatest surge in pre-registration gene therapy programs in over a year, with an 83% increase relative to Q3 2024. Consequently, the growing acceptance of gene therapy is propelling the expansion of the drug and gene delivery devices market.

Which Segments Are Driving Activity In The Drug And Gene Delivery Devices Market?

The drug and gene delivery devices market covered in this report is segmented –

1) By Vector: Viral, Non-viral

2) By Method: In Situ, Ex Vivo

3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical

Subsegments:

1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors

2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.

What Industry Trends Are Transforming The Drug And Gene Delivery Devices Market?

Major companies operating in the drug and gene delivery devices market are concentrating on developing advanced products, such as artificial intelligence (AI) technology, to gain a competitive advantage. Artificial intelligence (AI) technology in drug delivery refers to the application of AI techniques and algorithms to enhance the efficiency, precision, and effectiveness of drug delivery systems. For instance, in December 2023, Envoya Inc., a US-based developer of polymer-based nanoparticles for targeted delivery, launched an innovative gene therapy drug delivery platform. This platform combines biopolymer-nanoparticles with artificial intelligence (AI) to address significant limitations in current gene therapy technologies, such as viral vectors and lipid nanoparticles. The platform aims to overcome the restrictions of existing gene therapy delivery technologies, which have been challenged by safety concerns, limited payload capacities, and limited tissue targeting.

Which Major Industry Participants Are Leading The Drug And Gene Delivery Devices Market Growth?

Major companies operating in the drug and gene delivery devices market are Medtronic plc, Moderna Inc., Halozyme Therapeutics Inc., Uniqure NV, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation, ICU Medical, Stevanato Group, Gerresheimer AG, Ypsomed, SHL Medical

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-and-gene-delivery-devices-global-market-report

Which Region Is Projected To Lead The Drug And Gene Delivery Devices Market During The Forecast Period?

North America was the largest region in the drug and gene delivery devices market in 2025. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug And Gene Delivery Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19404&type=smp

Browse Through More Reports Similar to the Global Drug And Gene Delivery Devices Market 2026, By The Business Research Company

Gastrointestinal Drug Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Hematology Drug Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Metabolic Disorders Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company